<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01564953</url>
  </required_header>
  <id_info>
    <org_study_id>M-20110280</org_study_id>
    <nct_id>NCT01564953</nct_id>
  </id_info>
  <brief_title>Magnesium is Associated With QoL in COPD: A Cross-sectional Study</brief_title>
  <official_title>Serum Magnesium and Nit Vitamin D is Associated With Better QoL in COPD: A Cross-sectional Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study was to investigate the associations between serum concentrations of
      vitamin D, Magnesium and Calcium in Chronic obstructive pulmonary disease patients and the
      potential impact of these parameters on lung function and quality of life.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Attention is enhancing worldwide on the increasing tendency of insufficient 25-hydroxyvitamin
      D serum levels. New insights into the role of vitamin D and distribution of its receptors in
      the human body have been revealed. Presumably, this entails implications concerning disease
      and treatment that go far beyond the well-known field of bone-metabolism.

      Vitamin D deficiency is common in patients with chronic obstructive pulmonary disease (COPD),
      and reductions in vitamin D serum levels have formerly been perceived as a consequence rather
      than a cause of COPD.

      Yet, there is a lack of consensus concerning the role of vitamin D on the decreasing lung
      function in COPD.

      Some trials have revealed a high degree of co-variation between the grade of airway
      obstruction, intake of vitamin D and reduction of serum-vitamin D. Other claim that vitamin D
      appears to be capable of inhibiting pulmonary inflammatory responses.

      Vitamin D interacts with calcium and magnesium and this subtle balance might be highly
      relevant in the progression of inflammatory diseases like COPD. Presumably, Mg inhibits
      contraction and relaxes smooth muscles in airways due to blocking of calcium-ion-flux across
      the cell membrane.

      The aim of this study is to investigate the status of vitamin D, magnesium and calcium in
      COPD, and to study the relationship and impact of vitamin D, magnesium and calcium in
      COPD-patients.

      The hypothesis of this study is that COPD-patients with vitamin D-, magnesium- and calcium
      supplement have a better lung function and quality of life, than those who have vitamin D-,
      magnesium- and calcium deficiency.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Serum Vitamin D</measure>
    <time_frame>one year</time_frame>
    <description>vitamin D measured by p-25-hydroxy-vitamin D2 + D3, in mmol/L</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lung Function Test</measure>
    <time_frame>one year</time_frame>
    <description>Forced expiratory ventilation in 1 second, in percent of predicted</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Magnesium</measure>
    <time_frame>One year</time_frame>
    <description>Serum magnesium in plasma, in mmol/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Calcium</measure>
    <time_frame>One year</time_frame>
    <description>Serum ionized calcium, in mmol/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>One year</time_frame>
    <description>Quality of life measured by Chronic Obstructive Pulmonary Disease Assesment Test. Minimum score was 0 (no symptoms) and maximum score was 40 (many symptoms).</description>
  </secondary_outcome>
  <enrollment type="Actual">143</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease (COPD)</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples:

      p-creatinine p-potassium p-sodium p-albumine p-phosphate p-magnesium p-calcium-ion
      p-parathyrine p-25-hydroxy-vitamin D2 + D3
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Outpatients from the Department Of Resoiratory Diseases, Aarhus University Hospital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  COPD-patients

          -  Unchanged medical treatment for COPD for the last 4 weeks

          -  Outpatients

          -  adults over 40 years

        Exclusion Criteria:

          -  COPD exacerbation, which resulted in hospitalization and/or modification of medical
             treatment within 4 weeks

          -  Patients with other lung diseases, such as active tuberculosis, lung cancer,
             sarcoidosis and pulmonary fibrosis

          -  diseases affecting vitamin D and/or calcium and/or magnesium distribution

          -  Previous lung resection

          -  Treatment with systemic steroids

          -  Known addiction problems with alcohol and/or drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronald Dahl, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Allergy Centre, Odense University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sarah HA Hussein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Respiratory Diseases, Aarhus University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 26, 2012</study_first_submitted>
  <study_first_submitted_qc>March 27, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 28, 2012</study_first_posted>
  <results_first_submitted>May 31, 2015</results_first_submitted>
  <results_first_submitted_qc>January 13, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">March 6, 2017</results_first_posted>
  <last_update_submitted>January 13, 2017</last_update_submitted>
  <last_update_submitted_qc>January 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>vitamin D</keyword>
  <keyword>calcium</keyword>
  <keyword>magnesium</keyword>
  <keyword>COPD</keyword>
  <keyword>QoL</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Publish as paper in Scientific journal</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment took place in an outpatient clinic for respiratory diseases in Aarhus University Hospital, Denmark, during summertime in order to minimize seasonal variations of serum vitamin D.</recruitment_details>
      <pre_assignment_details>Missed inclusion was due to either unstable disease (54 patients) or unwillingness to participate (87 patients).</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Serum Vitamin D, Magnesium and Calcium Deficient Groups</title>
          <description>Participants were distributed into wether they were serum vitamin D, magnesium and calcium sufficiency or deficiency.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="143"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="143"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Serum Vitamin D, Magnesium and Calcium Deficient Groups</title>
          <description>Participants were distributed into wether they were serum vitamin D, magnesium and calcium sufficiency or deficiency.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="143"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="70" lower_limit="63" upper_limit="74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="66"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Denmark</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="143"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Serum Vitamin D</title>
        <description>vitamin D measured by p-25-hydroxy-vitamin D2 + D3, in mmol/L</description>
        <time_frame>one year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Serum Vitamin D</title>
            <description>Participants' serum vitamin D</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Vitamin D</title>
          <description>vitamin D measured by p-25-hydroxy-vitamin D2 + D3, in mmol/L</description>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="143"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.13" spread="33.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Lung Function Test</title>
        <description>Forced expiratory ventilation in 1 second, in percent of predicted</description>
        <time_frame>one year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lung Function</title>
            <description>lung function measured as forced expiratory volumes in 1 second.</description>
          </group>
        </group_list>
        <measure>
          <title>Lung Function Test</title>
          <description>Forced expiratory ventilation in 1 second, in percent of predicted</description>
          <units>percentage of predicted</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="143"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52" lower_limit="33" upper_limit="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Magnesium</title>
        <description>Serum magnesium in plasma, in mmol/L</description>
        <time_frame>One year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Serum Magnesium</title>
            <description>Serum magnesium in plasma, in mmol/L</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Magnesium</title>
          <description>Serum magnesium in plasma, in mmol/L</description>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="143"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.82" spread="0.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Calcium</title>
        <description>Serum ionized calcium, in mmol/L</description>
        <time_frame>One year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Serum Calcium</title>
            <description>Serum ionized calcium, in mmol/L</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Calcium</title>
          <description>Serum ionized calcium, in mmol/L</description>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="143"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.23" spread="0.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quality of Life</title>
        <description>Quality of life measured by Chronic Obstructive Pulmonary Disease Assesment Test. Minimum score was 0 (no symptoms) and maximum score was 40 (many symptoms).</description>
        <time_frame>One year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Quality of Life</title>
            <description>Quality of life measured by Chronic Obstructive Pulmonary Disease Assesment Test</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Life</title>
          <description>Quality of life measured by Chronic Obstructive Pulmonary Disease Assesment Test. Minimum score was 0 (no symptoms) and maximum score was 40 (many symptoms).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="143"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24" lower_limit="22" upper_limit="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <description>Adverse Events were not collected for the 143 participants</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The cross-sectional design. Some data (e.g. number of exacerbations past one year and smoking history) were self-reported and therefore, a risk of recall-bias cannot be excluded.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Sarah Hashim Ali Hussein</name_or_title>
      <organization>Aarhus University Hospital</organization>
      <phone>0045 42660308</phone>
      <email>sarsuri@hotmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

